Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: A loss of skeletal muscle mass is frequently observed in older adults. The aim of the study was to investigate the impact of type 2 diabetes on the changes in body composition, with particular interest in the skeletal muscle mass. RESEARCH DESIGN AND METHODS: We examined total body composition with dual-energy X-ray absorptiometry annually for 6 years in 2,675 older adults. We also measured mid-thigh muscle cross-sectional area (CSA) with computed tomography in year 1 and year 6. At baseline, 75-g oral glucose challenge tests were performed. Diagnosed diabetes (n = 402, 15.0%) was identified by self-report or use of hypoglycemic agents. Undiagnosed diabetes (n = 226, 8.4%) was defined by fasting plasma glucose (≥7 mmol/l) or 2-h postchallenge plasma glucose (≥11.1 mmol/l). Longitudinal regression models were fit to examine the effect of diabetes on the changes in body composition variables. RESULTS: Older adults with either diagnosed or undiagnosed type 2 diabetes showed excessive loss of appendicular lean mass and trunk fat mass compared with nondiabetic subjects. Thigh muscle CSA declined two times faster in older women with diabetes than their nondiabetic counterparts. These findings remained significant after adjusting for age, sex, race, clinic site, baseline BMI, weight change intention, and actual weight changes over time. CONCLUSIONS: Type 2 diabetes is associated with excessive loss of skeletal muscle and trunk fat mass in community-dwelling older adults. Older women with type 2 diabetes are at especially high risk for loss of skeletal muscle mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both cross-sectional and longitudinal studies, accelerated loss of muscle mass and strength is recorded in individuals with diabetes, is greater with longer diabetes duration or higher HbA1c, and is attenuated by use of insulin sensitisers.36-38”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, data from the HealthABC study (2) showed an excessive loss of skeletal muscle mass in older adults with type 2 diabetes was two times faster than those without diabetes.”
From Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction (2011) · cites this paper as [2]
Experimental — accuracy not yet measuredIn the citing paper
“Mild muscle atrophy is common in middle-aged T2D patients and becomes more significant during older age and diabetic neuropathy.205,206”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [205]
In the citing paper
“Hyperglycaemia predicts persistently lower muscle strength with aging [54], and an excessive loss of skeletal muscle mass has been detected in older adults with type 2 diabetes [55].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550 · cited 2×
“1 Proc Genmod) developed by Liang and Zeger (15).”
BackgroundInfluentialWild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“Both conditions often remain unrecognized since onethird of type 2 diabetic subjects are still undiagnosed (20,21).”
BackgroundNewman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Self-citationVisser, M., Goodpaster, B. H., Kritchevsky, S. B., Newman, A. B., Nevitt, M., Rubin, S. M., Simonsick, E. M., Harris, T. B., & Study, F. T. H. A. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.3.324 · Cited by 1,403
Self-citationHughes, V. A., Frontera, W. R., Roubenoff, R., Evans, W. J., & Singh, M. A. F. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.473 · Cited by 804 · cited 1×
“The finding of our study on sex difference is very consistent with previous studies showing that declines in muscle mass were almost always greater in men than in women (16,17).”
ResultAccelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766 · cited 2×
“Our previous report on the changes of muscle strength in the same population suggested that differential follow-up rate or non-random missing biased the result to the null (6).”
BackgroundSelf-citationDecreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., & Newman, A. B. (2006) · Diabetes · doi:10.2337/db05-1183 · Cited by 751 · cited 1×
“We have observed cross-sectionally that older adults with type 2 diabetes have an altered body composition and low skeletal muscle strength compared with nondiabetic older adults (5).”
BackgroundSelf-citationEndurance Exercise as a Countermeasure for Aging
Lanza, I. R., Short, D. K., Short, K. R., Raghavakaimal, S., Basu, R., Joyner, M. J., McConnell, J. P., & Nair, K. S. (2008) · Diabetes · doi:10.2337/db08-0349 · Cited by 582
Visser, M., Fuerst, T., Lang, T., Salamone, L., Harris, T. B., Health, F. T., Absorptiometry, A., & Group, B. C. W. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.4.1513 · Cited by 422
Self-citationChanges in Body Weight and Body Fat Distribution as Risk Factors for Clinical Diabetes in US Men
Koh-Banerjee, P., Wang, Y., Hu, F. B., Spiegelman, D., Willett, W. C., & Rimm, E. B. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh167 · Cited by 361 · cited 1×
“In addition, although weight gain and accumulation of abdominal fat have been known as strong risk factors for the development of type 2 diabetes (4), the changes in body composition after the onset of diabetes are not well documented.”
Background
Cited by
Items 101–200 of 781
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
Simes, B. C., & MacGregor, G. G. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s212003 · Cited by 103
“Patients with diabetes show decreased cardiovascular fitness, skeletal muscle mass and overall physical activity levels.(51,52) Multiple studies have demonstrated that glitazones and glucagon-like peptide-1 (GLP-1) agonists have positive effects on cardiovascular fitness.”
BackgroundAbe, T., Loenneke, J. P., Thiebaud, R. S., & Fukunaga, T. (2013) · AGE · doi:10.1007/s11357-013-9600-5 · Cited by 120
Ostler, J. E., Maurya, S. K., Dials, J., Roof, S. R., Devor, S. T., Ziolo, M. T., & Periasamy, M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00277.2013 · Cited by 102
“AS HUMANS AGE, IT IS COMMON for skeletal muscle mass and function to deteriorate (14, 22, 36).”
BackgroundInfluentialFung, F. Y., Koh, Y. L. E., Malhotra, R., Østbye, T., Lee, P. Y., Ghazali, S. S., & Tan, N. C. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1137-8 · Cited by 110
Hormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 122
Diabetes pharmacotherapy and effects on the musculoskeletal system
Kalaitzoglou, E., Fowlkes, J. L., Popescu, I., & Thrailkill, K. M. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3100 · Cited by 100
“In humans with T2D, greater muscle mass due to larger body size may exist, compared with healthy adults; however, their muscle performance is negatively affected.457 Also, with age, muscle wasting in patients withT2D is evident.431 In certain animal models of T2D, such as the db/db mice, decreased exercise capacity an…”
BackgroundInfluentialPrevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions
Jun, L., Robinson, M., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032973 · Cited by 115
“The effects of T1DM on protein metabolism seem to be clear as insulin deficiency leads to a profound increase in catabolism [76], reduced motility of myosin, and altered mitochondrial ultrastructure and function [71,77,78].”
BackgroundAnton, S. D., Karabetian, C., Naugle, K., & Buford, T. W. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.06.007 · Cited by 100
“Compared to peers with a body mass index (BMI; kg/m2) in the healthy range (i.e., 20–24.9 kg/m2), obese older adults with a BMI ≥ 30 kg/m2 experience impairments in basic activities of daily living approximately five years earlier and are twice as likely to develop impairments in function and/or activities of daily li…”
InfluentialGheller, B. J. F., Riddle, E. S., Lem, M. R., & Thalacker-Mercer, A. E. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050901 · Cited by 98
López-Pedrosa, J. M., Camprubí-Robles, M., Rolo, G. G., Lopez-Gonzalez, A., García‐Almeida, J. M., Sanz‐París, A., & Rueda, R. (2024) · Nutrients · doi:10.3390/nu16010172 · Cited by 116
Pownall, H. J., Bray, G. A., Wagenknecht, L. E., Walkup, M. P., Heshka, S., Hubbard, V. S., Hill, J., Kahn, S. E., Nathan, D. M., Schwartz, A. V., et al. (2015) · Obesity · doi:10.1002/oby.21005 · Cited by 94
“Diet and various diseases, especially diabetes, also affect LM loss, particularly in older individuals (12-20).”
BackgroundTabara, Y., Ikezoe, T., Yamanaka, M., Setoh, K., Segawa, H., Kawaguchi, T., Kosugi, S., Nakayama, T., Ichihashi, N., Tsuboyama, T., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly233 · Cited by 98
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications
Zhang, X., Zhao, Y., Chen, S., & Shao, H. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12838 · Cited by 92
“Older people with diabetes are twice more likely to develop sarcopenia than those without diabetes.(6,7) The strength and resistance of skeletal muscle decreased significantly in type 2 diabetes mellitus (T2DM) patients.”
BackgroundSleep duration and sarcopenia risk: a systematic review and dose-response meta-analysis
Pourmotabbed, A., Ghaedi, E., Babaei, A., Mohammadi, H., Khazaie, H., Jalili, C., Symonds, M. E., Moradi, S., & Miraghajani, M. S. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01965-6 · Cited by 98
Temporalis muscle morphomics: the psoas of the craniofacial skeleton
Ranganathan, K., Terjimanian, M. N., Lisiecki, J. L., Rinkinen, J. R., Mukkamala, A., Brownley, C., Buchman, S. R., Wang, S. C., & Lévi, B. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.07.059 · Cited by 91
“[7] Park SW, Goodpaster BH, Lee JS, et al.”
BackgroundMori, H., Kuroda, A., Yoshida, S., Yasuda, T., Umayahara, Y., Shimizu, S., Ryomoto, K., Yoshiuchi, K., Yamamoto, T., Matsuoka, T., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13436 · Cited by 90
Lee, J. S. W., Auyeung, T. W., Leung, J. C. S., Kwok, T. C. Y., Leung, P.-C., & Woo, J. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0134-1 · Cited by 97
Self-citationEshima, H., Tamura, Y., Kakehi, S., Kurebayashi, N., Murayama, T., Nakamura, K., Kakigi, R., Okada, T., Sakurai, T., Kawamori, R., et al. (2017) · Physiological Reports · doi:10.14814/phy2.13250 · Cited by 88
“Metabolic disorders, such as insulin resistance and type 2 diabetes mellitus, can cause a decrease in muscle strength and loss of muscle mass (Park et al. 2006, 2009; Zhou et al. 2007; Lee et al. 2011).”
BackgroundDiabetes, peripheral neuropathy, and lower-extremity function
Shaffer, N. C., Phillips, C. L., Volpato, S., Bandinelli, S., Ferrucci, L., Guralnik, J. M., & Patel, K. V. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.08.007 · Cited by 100
“…muscle mass and strength, longitudinal research is needed to assess and quantify these relationships as explanatory factors of poorer physical function among diabetic versus nondiabetic older adults (Resnick et al., 2002; Park et al., 2006; Park et al., 2009; Morley, 2008; Strotmeyer et al., 2009).”
Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation
Murai, J., Nishizawa, H., Otsuka, A., Fukuda, S., Tanaka, Y., Nagao, H., Sakai, Y., Suzuki, M., Yokota, S., Tada, H., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0755-3 · Cited by 90
Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies
Dodson, R. M., Firoozmand, A., Hyder, O. N., Tacher, V., Cosgrove, D., Bhagat, N., Herman, J. M., Wolfgang, C. L., Geschwind, J.-F. H., Kamel, I. R., et al. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2348-5 · Cited by 91
Dynapenic obesity and the risk of incident Type 2 diabetes: the english longitudinal study of ageing
Cuthbertson, D. J., Bell, J. A., Ng, S. Y., Kemp, G. J., Kivimaki, M., & Hamer, M. (2016) · Diabetic Medicine · doi:10.1111/dme.12991 · Cited by 86
“12 diagnosed with T2DM, compared with age- and BMI-matched healthy controls [29].”
BackgroundSarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors
Rizzo, M. R., Barbieri, M., Fava, I., Desiderio, M., Coppola, C., Marfella, R., & Paolisso, G. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.04.016 · Cited by 93
Kalyani, R. R., Metter, E. J., Ramachandran, R., Chia, C. W., Saudek, C. D., & Ferrucci, L. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr022 · Cited by 86
“2012 January;67A(1):74–81 All rights reserved.”
MethodInfluentialBauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00561-w · Cited by 83
Xiao, J., Caan, B. J., Weltzien, E., Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Baracos, V. E., Kwan, M. L., Castillo, A. L., & Prado, C. M. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12301 · Cited by 84
Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes
Sala, D., Ivanova, S., Plana, N., Ribas, V., Duran, J., Bach, D., Turkseven, S., Laville, M., Vidal, H., Karczewska-Kupczewska, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72327 · Cited by 86
“In contrast, type 2 diabetes is characterized by greater muscle mass (22, 38, 41).”
Orlando, G., Balducci, S., Bazzucchi, I., Pugliese, G., & Sacchetti, M. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2658 · Cited by 99
“This decline has been documented in both cross-sectional and longitudinal studies and appears to affect primarily the appendicular musculature and particularly the lower limbs [18,34].”
BackgroundManagement of Type 2 Diabetes Mellitus in Older Adults
Kim, K., Kim, S. K., Sung, K. M., Cho, Y., & Park, S. W. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.336 · Cited by 99
Self-citationSarcopenia and its associated factors in Iranian older individuals: Results of SARIR study
Hashemi, R., Shafiee, G., Motlagh, A. D., Pasalar, P., Esmailzadeh, A., Siassi, F., Larijani, B. A., & Heshmat, R. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.04.016 · Cited by 88
“Diabetes is associated with lower muscle mass as well as lower strength and quality of muscle (Park et al., 2009) The present study had several limitations that should be recognized.”
Sarcopenia, frailty and type 2 diabetes mellitus (Review)
Nishikawa, H., Fukunishi, S., Asai, A., Yokohama, K., Ohama, H., Nishiguchi, S., & Higuchi, K. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12494 · Cited by 84
Liu, L.-K., Lee, W., Chen, L., Hwang, A., Ming‐Hsien, L. I. N., Peng, L., & Chen, L. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12208 · Cited by 92
Wander, P. L., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Kahn, S. E., & Fujimoto, W. Y. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.01.007 · Cited by 91
“In cross-sectional studies, hand-grip strength (hand-grip strength) was lower in individuals with diabetes than in those without [2,3], and type 2 diabetes has recently been shown to be associated with skeletal muscle loss over time [4].”
Resistance Training and Older Adults with Type 2 Diabetes Mellitus: Strength of the Evidence
Hovanec, N., Sawant, A., Overend, T. J., Petrella, R. J., & Vandervoort, A. A. (2012) · Journal of Aging Research · doi:10.1155/2012/284635 · Cited by 79
“, greater loss in the amount of leg lean mass) when compared with healthy, age-matched counterparts [20, 22].”
BackgroundResultLong acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents
Gurjar, A. A., Kushwaha, S., Chattopadhyay, S., Das, N., Pal, S., China, S. P., Kumar, H., Trivedi, A. K., Guha, R., Chattopadhyay, N., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2019.154044 · Cited by 79
Zanuso, S., Sacchetti, M., Sundberg, C. J., Orlando, G., Benvenuti, P., & Balducci, S. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096724 · Cited by 77
Mesinovic, J., McMillan, L. B., Shore‐Lorenti, C., de Courten, B. V., Ebeling, P. R., & Scott, D. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020145 · Cited by 81
“Indeed, low muscle mass has been associated with increased risk of incident T2DM [48], and T2DM has also been reported to be associated with the loss of skeletal muscle mass [49].”
BackgroundRisk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin
Chen, F., Xu, S., Wang, Y., Chen, F., Cao, L., Liu, T., Huang, T., Qian, W., Ma, G., Zhao, Y., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3950404 · Cited by 85
“Other research has also shown that older adults with T2DM have an accelerated loss in muscle mass and strength compared with adults without diabetes [18, 36] and that the prevalence of sarcopenia in patients with diabetes was significantly higher than in nondiabetic subjects.”
BackgroundResultMuscle protein anabolism in type 2 diabetes
Bassil, M. S., & Gougeon, R. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32835a88ee · Cited by 77
Changes in Cells Associated with Insulin Resistance
Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 88
The Growing Role of Technology in the Care of Older Adults With Diabetes
Huang, E. S., Sinclair, A., Conlin, P. R., Cukierman-Yaffe, T., Hirsch, I. B., Huisingh-Scheetz, M., Kahkoska, A. R., Laffel, L., Lee, A. K., Lee, S., et al. (2023) · Diabetes Care · doi:10.2337/dci23-0021 · Cited by 73
A Novel Cellular Defect in Diabetes
Howard, A. C., McNeil, A. K., Xiong, F., Xiong, W., & McNeil, P. L. (2011) · Diabetes · doi:10.2337/db11-0851 · Cited by 77
“Atrophy can be severe and debilitating (4), affecting most prominently the proximal limb-girdle muscle, a condition referred to as “diabetic amyotrophy” (5).”
BackgroundCodella, R., Ialacqua, M., Terruzzi, I., & Luzi, L. (2018) · Endocrine · doi:10.1007/s12020-018-1603-7 · Cited by 72
Zhou, H., Liao, Y., Peng, Z., Liu, F., Wang, Q., & Yang, W. Q. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13263 · Cited by 85
“Observational studies have demonstrated that accelerated loss of muscle mass was found in diabetes patients.(123,124) It was suggested that dysglycaemia and insulin resistance are important risk factors for advanced muscle wasting in diabetes.”
BackgroundVitamin D Signaling in Myogenesis: Potential for Treatment of Sarcopenia
Wagatsuma, A., & Sakuma, K. (2014) · BioMed Research International · doi:10.1155/2014/121254 · Cited by 71
“Therefore, elderly people with excessive loss of muscle mass are at risk for development of type 2 diabetes mellitus [87].”
BackgroundHashimoto, Y., Osaka, T., Fukuda, T., Tanaka, M., Yamazaki, M., & Fukui, M. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0124 · Cited by 72
“Recent studies revealed that type 2 diabetes is associated with sarcopenia [1-4], which is characterized by age-related decline of skeletal muscle plus low muscle strength and/or physical performance [5].”
BackgroundWetzlich, B., Nyakundi, B. B., & Yang, J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05120-y · Cited by 78
“Additionally, increasing functional muscle mass (assuming it is possible) would be beneficial for treating diabetes, as a loss of skeletal muscle mass is frequently associated with both T1DM and T2DM due to catabolism caused by malfunction of insulin-related issues [123].”
The effect of diabetes mellitus on age‐associated lean mass loss in 3153 older adults
Lee, J. S. W., Auyeung, T. W., Leung, J. C. S., Kwok, T. C. Y., Leung, P., & Woo, J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03118.x · Cited by 73
Self-citationEffect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes
Mansour, A., Tehrani, M. R. M., Qorbani, M., Heshmat, R., Larijani, B. A., & Hosseini, S. (2014) · Nutrition · doi:10.1016/j.nut.2014.05.014 · Cited by 73
“A recent study found rapid decline in appendicular lean mass, in particular thigh muscle mass, in patients with diabetes compared with individuals without the disease [10].”
BackgroundInfluentialMid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity
Ma, J., Hwang, S., McMahon, G. M., Curhan, G. C., Mclean, R. R., Murabito, J. M., & Fox, C. S. (2016) · Obesity · doi:10.1002/oby.21356 · Cited by 68
“Previous studies have shown that hyperglycemia or type 2 diabetes was associated with sarcopenia (30-32).”
BackgroundActive vitamin D possesses beneficial effects on the interaction between muscle and bone
Tanaka, K.-I., Kanazawa, I., Yamaguchi, T., Yano, S., Kaji, H., & Sugimoto, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.145 · Cited by 73
“On the other hand, several studies have shown that sarcopenia is associated with diabetes 3 mellitus (20-23).”
BackgroundMuscle strength and ankle mobility for the gait parameters in diabetic neuropathies
Martinelli, A. R., Mantovani, A. M., Nozabieli, A. J. L., Ferreira, D. M. A., Barela, J. Â., de Camargo, M. R., & Fregonesi, C. E. P. T. (2012) · The Foot · doi:10.1016/j.foot.2012.11.001 · Cited by 68
Insulin resistance of amino acid and protein metabolism in type 2 diabetes
Tessari, P., Cecchet, D., Cosma, A., Puricelli, L., Millioni, R., Vedovato, M., & Tiengo, A. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.02.009 · Cited by 79
Bahrmann, A., Bahrmann, P., Baumann, J., Bauer, J. M., Brückel, E., Dreyer, M., Freitag, M., Friedl, A., Gölz, S., Grundke, S., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0666-0820 · Cited by 71
Castillo, Í. M. P., Argilés, J. M. A., Rueda, R., Ramírez, M., & Pedrosa, J. M. L. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09954-9 · Cited by 81
“T2DM patients display skeletal muscle atrophy denoted by greater loss of muscle mass compared to age-matched subjects without diabetes [18, 19].”
Aerobic exercise training in the treatment of non‐alcoholic fatty liver disease related fibrosis
Linden, M. A., Sheldon, R. D., Meers, G. M., Ortinau, L. C., Morris, E. M., Booth, F. W., Kanaley, J. A., Vieira‐Potter, V. J., Sowers, J. R., Ibdah, J. A., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272235 · Cited by 68
Francia, P., Gulisano, M., Anichini, R., & Seghieri, G. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140507112536 · Cited by 84
Abe, T., Loenneke, J., Young, K. C., Thiebaud, R., Nahar, V., Hollaway, K. M., Stover, C. D., Ford, M., Bass, M., & Loftin, M. (2015) · Ultrasound in Medicine and Biology · doi:10.1016/j.ultrasmedbio.2014.09.007 · Cited by 65
“Reduced aLM is closely associated with increased risk of physical disability (Baumgartner et al. 1998; Janssen et al. 2002; Tanimoto et al. 2012), cognitive decline (Burns et al. 2010), metabolic disorders (Abe et al. 2012b; Park et al. 2009) and mortality (Bunout et al. 2011; Vetrano et al. 2014).”
BackgroundInsulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes
Bouchi, R., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0251-x · Cited by 64
Shabkhiz, F., Khalafi, M., Rosenkranz, S., Karimi, P., & Moghadami, K. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2020.1762755 · Cited by 64
“Our results demonstrate that T2D associated with reduction in muscle strength, and decreases in muscle strength commonly observed with diabetes are greatly related to impairments in loss of muscle mass (Park et al., 2006, 2007, 2009).”
ResultBotton, C. E., Umpierre, D., Rech, A., Pfeifer, L. O., Machado, C. L. F., Teodoro, J. L., Dias, A. S., & Pinto, R. S. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.10.001 · Cited by 74
Lee, E. Y., Lee, Y., Yi, S., Shin, S., & Yi, J. (2017) · Diabetes Care · doi:10.2337/dc16-1458 · Cited by 67
Huo, L., Shaw, J. E., Wong, E., Harding, J. L., Peeters, A., & Magliano, D. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3948-x · Cited by 62
“Additionally, non-traditional diabetes-related problems, such as cognitive impairment and sarcopenia [29–31], could also be the potential mechanisms that cause disability.”
BackgroundChiu, C., Du, Y., Ou, H., & Beverly, E. A. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s53482 · Cited by 78
Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes: Expert document
de Luis, D. A., Carretero‐Gómez, J., García‐Almeida, J. M., Vallo, F. G., Rolo, G. G., Gómez, J. J. L., Tarazona‐Santabalbina, F. J., & Sanz‐París, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09871-9 · Cited by 69
Diagnostic criteria for sarcopenia relate differently to insulin resistance
Bijlsma, A. Y., Meskers, C. G. M., van Heemst, D., Westendorp, R. G. J., de Craen, A. J. M., & Maier, A. B. (2013) · AGE · doi:10.1007/s11357-013-9516-0 · Cited by 69
Gupta, P., Lança, C., Gan, A. T. L., Soh, P., Thakur, S., Tao, Y., Neelam, K., Man, R. E. K., Fenwick, E., & Lamoureux, E. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-49162-5 · Cited by 74
The effect of type 2 diabetes mellitus and obesity on muscle progenitor cell function
Teng, S., & Huang, P. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1186-0 · Cited by 59
Merchant, R. A., Chan, Y. H., Lim, J. Y., & Morley, J. E. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s260544 · Cited by 54
Du, H., Ma, Y., Wang, X., Zhang, Y., Zhu, L., Shi, S., Pan, S., & Liu, Z. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2022 · Cited by 64
Tanaka, K.-I., Kanazawa, I., & Sugimoto, T. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-9990-8 · Cited by 63
Bouchi, R., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2957 · Cited by 57
Strasser, E.-M., Hofmann, M., Franzke, B., Schober-Halper, B., Oesen, S., Jandrasits, W., Graf, A. C., Praschak, M., Horvath-Mechtler, B., Krammer, C., et al. (2019) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.18.04930-4 · Cited by 71
Zhang, X., Trevino, M. B., Wang, M., Gardell, S. J., Ayala, J. E., Han, X., Kelly, D. P., Goodpaster, B. H., Vega, R. B., & Coen, P. M. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly051 · Cited by 58
Self-citationProteomic Identification of Biomarkers of Skeletal Muscle Disorders
Ohlendieck, K. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.12.96 · Cited by 70
Kim, J. E., Lee, Y., Huh, J. H., Kang, D. R., Rhee, Y., & Lim, S.-K. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2745-y · Cited by 66
“Absolute muscle mass without the adjustment of body mass has been found to be associated with higher insulin resistance in some cross-sectional studies [17–19], although relative muscle mass was inversely associated with insulin resistance after the standardization of other variables [20, 21].”
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets
Volek, J. S., Phinney, S. D., Krauss, R. M., Johnson, R. J., Saslow, L. R., Gower, B., Yancy, W. S., King, J. C., Hecht, F. M., Teicholz, N., et al. (2021) · Nutrients · doi:10.3390/nu13103299 · Cited by 57
“Individuals with T2D typically lose 8% of their lean muscle mass every decade from age 40 and 15% per decade from age 70 [166].”
BackgroundMusculoskeletal complications in patients with diabetes mellitus
Choi, J. H., Kim, H., & Song, K. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.168 · Cited by 71
“In another study, elderly women with T2DM exhibited about twice as much muscle mass loss than non-diabetic women after 6 years of follow-up [104].”
BackgroundOptimal therapy of type 2 diabetes: a controversial challenge
Dardano, A., Penno, G., Prato, S. D., & Miccoli, R. (2014) · Aging · doi:10.18632/aging.100646 · Cited by 68
Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention
Rejeski, W. J., Bray, G. A., Chen, S.-H., Clark, J. M., Evans, M., Hill, J. O., Jakicic, J. M., Johnson, K. C., Neiberg, R., Ip, E. H., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu083 · Cited by 56
Acacetin enhances glucose uptake through insulin-independent GLUT4 translocation in L6 myotubes
Kwon, E., Kang, M.-J., Ryu, H. W., Lee, S., Lee, J., Lee, M. K., Lee, H.-S., Lee, S. U., Oh, S., & Kim, M.-O. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153178 · Cited by 56
Self-citationMuscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
Muscaritoli, M., Lucia, S., Molfino, A., Cederholm, T., & Fanelli, F. R. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0807-8 · Cited by 73
Abe, T., Thiebaud, R., Loenneke, J., & Young, K. (2015) · AGE · doi:10.1007/s11357-015-9853-2 · Cited by 55
Pan, X., Han, Y., Zou, T., Zhu, G., Xu, K., Zheng, J., Zheng, M., & Cheng, X. (2018) · Digestive Diseases · doi:10.1159/000491015 · Cited by 56
Low muscle mass in older men: The role of lifestyle, diet and cardiovascular risk factors
Atkins, J. L., Whincup, P. H., Morris, R. W., & Wannamethee, S. G. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0336-9 · Cited by 55
Laviano, A., Gori, C. S., & Rianda, S. (2014) · Advances in food and nutrition research · doi:10.1016/b978-0-12-800270-4.00003-1 · Cited by 68
Multimorbidity, Frailty and Diabetes in Older People–Identifying Interrelationships and Outcomes
Sinclair, A. J., & Abdelhafiz, A. H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111911 · Cited by 66
Abe, T., Patterson, K. M., Stover, C. D., Geddam, D. A. R., Tribby, A. C., Lajza, D. G., & Young, K. C. (2014) · AGE · doi:10.1007/s11357-014-9634-3 · Cited by 60
Lee, C. G., Schwartz, A. V., Yaffe, K., Hillier, T. A., LeBlanc, E. S., Cawthon, P. M., & the Study of Osteoporotic Fractures Research Group (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12502 · Cited by 53
Pasman, W. J., Memelink, R. G., de Vogel-Van den Bosch, J., Begieneman, M. P. V., van den Brink, W. J., Weijs, P. J. M., & Wopereis, S. (2020) · Nutrients · doi:10.3390/nu12102979 · Cited by 52
“This is especially problematic in the obese older diabetic population, as these individuals not only suffer from decreased glycemic control but also are at risk of losing skeletal muscle mass [8].”
BackgroundType 2 diabetes and impaired physical function: a growing problem
Ahmad, E., Sargeant, J. A., Yates, T., Webb, D. R., & Davies, M. J. (2022) · Diabetology · doi:10.3390/diabetology3010003 · Cited by 52
McGinley, S. K., Armstrong, M. J., Boulé, N. G., & Sigal, R. J. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0594-y · Cited by 60
“Diabetes is an independent risk factor for lower muscular strength, especially in those with poor glycaemic control [48, 50], and is associated with two to three times increased odds of disability [51].”
BackgroundMetabolites Associated With Lean Mass and Adiposity in Older Black Men
Murphy, R. A., Moore, S. C., Playdon, M. C., Meirelles, O., Newman, A. B., Milijkovic, I., Kritchevsky, S. B., Schwartz, A. V., Goodpaster, B. H., Sampson, J. N., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw245 · Cited by 55
Self-citationMiyake, H., Kanazawa, I., Tanaka, K.-I., & Sugimoto, T. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819842971 · Cited by 57
Memelink, R. G., Pasman, W. J., Bongers, A., Tump, A. C., van Ginkel, A., Tromp, W., Wopereis, S., Verlaan, S., den Bosch, J. D. V., & Weijs, P. J. M. (2020) · Nutrients · doi:10.3390/nu13010064 · Cited by 65
Risk factors for surgery-related muscle quantity and muscle quality loss and their impact on outcome
van Wijk, L., van Duinhoven, S., Liem, M. S. L., Bouman, D. E., Viddeleer, A. R., & Klaase, J. M. (2021) · European journal of medical research · doi:10.1186/s40001-021-00507-9 · Cited by 61
“The impaired insulin function may cause the loss of body protein, particularly during the katabolic postoperative period [23, 24].”
BackgroundEnhancement of anaerobic glycolysis – a role of PGC-1α4 in resistance exercise
Koh, J.-H., Pataky, M. W., Dasari, S., Klaus, K. A., Vuckovic, I., Ruegsegger, G. N., Kumar, A. P., Robinson, M. M., & Nair, K. S. (2022) · Nature Communications · doi:10.1038/s41467-022-30056-6 · Cited by 50
The Prevalence of Presarcopenia in Asian Indian Individuals With and Without Type 2 Diabetes
Anbalagan, V. P., Venkataraman, V., Pradeepa, R., Deepa, M., Anjana, R. M., & Mohan, V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0068 · Cited by 50
“However, in the Health, Aging, and Body Composition Study that was done on elderly subjects, individuals with T2DM exhibited increases in both lean body mass and body fat mass compared with individuals without diabetes, possibly because, compared with subjects without diabetes, those with diabetes had higher BMI.(23,3…”
Skeletal muscle – A bystander or influencer of metabolic syndrome?
Richter-Stretton, G. L., Fenning, A. S., & Vella, R. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.006 · Cited by 55
The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass
Fujimaki, S., Matsumoto, T., Muramatsu, M., Nagahisa, H., Horii, N., Seko, D., Masuda, S., Wang, X., Asakura, Y., Takahashi, Y., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00533-9 · Cited by 55
Metadata
- Authors
- Park, S. W., Goodpaster, B. H., Lee, J. S., Kuller, L. H., Boudreau, R., de Rekeneire, N., Harris, T. B., Kritchevsky, S., Tylavsky, F. A., Nevitt, M., Cho, Y.-W., Newman, A. B., & for the Health, A.
- Affiliations
- CHA University (KR)
- University of Pittsburgh (US)
- University of Georgia (US)
- Center on Disability and Disabling Disorders, Yale University School of Medicine, New Haven, Connecticut;
- National Institutes of Health (US)
- Wake Forest University Health Sciences (US)
- University of Tennessee Health Science Center (US)
- University of California, San Francisco (US)
- Corresponding author
- Park, Seok Won
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-23
- Volume
- 32
- Issue
- 11
- Pages
- 1993-1997
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768193
- OpenAlex
- W2153229820
- Cited by
- 778
- References
- 22
- Citations by year
- 2026: 37 · 2025: 58 · 2024: 62 · 2023: 53 · 2022: 63 · 2021: 64 · 2020: 57 · 2019: 43 · 2018: 47 · 2017: 62 · 2016: 44 · 2015: 43 · 2014: 50 · 2013: 32 · 2012: 27
- FWCI
- 13.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (N01‐AG‐6–2101, N01AG62106, N01-AG-62103, P30AG021332)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- type 2 diabetes, skeletal muscle mass, sarcopenia, body composition, older adults, undiagnosed diabetes, appendicular lean mass, trunk fat mass, thigh muscle cross-sectional area, muscle mass loss
- MeSH terms
- Adipose Tissue, Aged, Aging, Blood Glucose, Body Composition, Body Weight, Diabetes Mellitus, Type 2, Enzyme-Linked Immunosorbent Assay, Female, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Male, Middle Aged, Organ Size, Regression Analysis, Tumor Necrosis Factor-alpha, Absorptiometry, Photon, Interleukin-6, Body Mass Index, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
